Maintenance of IKKβ activity is necessary to protect lung grafts from acute injury

Transplantation

Volumn 91, Issue 6, 2011, Pages 624-631

  Huang, Howard J ^a   Sugimoto, Seiichiro ^b   Lai, Jiaming ^b   Okazaki, Mikio ^b   Yamamoto, Sumiharu ^b   Krupnick, Alexander S ^b   Kreisel, Daniel ^b   Gelman, Andrew E ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lung injury; IKK ; Ischemia reperfusion; Lung transplantation; Primary graft dysfunction

Indexed keywords

ASPARTYLARGINYLGLUTAMINYLISOLEUCYLLYSYLISOLEUCYLTRYPTOPHANYLPHENYLALANYLGLUTAMINYLASPARAGINYLARGINYLARGINYLMETHIONYLLYSYLTRYPTOPHANYLLYSYLLYSYLTHREONYLALANYLLEUCYLASPARTYLALANYLSERYLALANYLLEUCYLGLUTAMINYLTHREONYLGLUTAMIC ACID; ASPARTYLARGINYLGLUTAMINYLISOLEUCYLLYSYLISOLEUCYLTRYPTOPHANYLPHENYLALANYLGLUTAMINYLASPARAGINYLARGINYLARGINYLMETHIONYLLYSYLTRYPTOPHANYLLYSYLLYSYLTHREONYLALANYLLEUCYLASPARTYLTRYTOPHANYLSERYLTRYPTOPHANYLLEUCYLGLUTAMINYLTHREONYLGLUTAMIC ACID; AUTACOID; ENZYME INHIBITOR; I KAPPA B KINASE BETA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; ISCHEMIA; LOW DRUG DOSE; LUNG FUNCTION; LUNG TRANSPLANTATION; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; REPERFUSION INJURY;

ACUTE LUNG INJURY; ANIMALS; BINDING SITES; I-KAPPA B KINASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG TRANSPLANTATION; MICE; MICE, INBRED C57BL; NF-KAPPA B; REPERFUSION INJURY;

EID: 79952744076     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31820ba2a0     Document Type: Article

References (37)

1. de Perrot M, Liu M, Waddell TK, et al. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167: 490.
2. Huang HJ, Yusen RD, Meyers BF, et al. Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant 2008; 8: 2454.
3. Bharat A, Kuo E, Steward N, et al. Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg 2008; 86: 189.
4. Lee JC, Christie JD. Primary graft dysfunction. Proc Am Thorac Soc 2009; 6: 39.
5. Ross SD, Kron IL, Gangemi JJ, et al. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factorkappaB. Am J Physiol Lung Cell Mol Physiol 2000; 279: L528.
6. Rothwarf DM, Zandi E, Natoli G, et al. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 1998; 395: 297.
7. Zandi E, Rothwarf DM, Delhase M, et al. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997; 91: 243.
8. Karin M. How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene 1999; 18: 6867.
9. Senftleben U, Cao Y, Xiao G, et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001; 293: 1495.
10. Li ZW, Chu W, Hu Y, et al. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 1999; 189: 1839.
11. Karin M, Delhase M. The IkappaB kinase (IKK) and NF-kappa B: Key elements of proinflammatory signalling. Semin Immunol 2000; 12(1): 85.
12. Luo JL, Kamata H, Karin M. The anti-death machinery in IKK/NFkappaB signaling. J Clin Immunol 2005; 25: 541.
13. Karin M, Yamamoto Y, Wang QM. The IKK NF-kappa B system: A treasure trove for drug development. Nat Rev Drug Discov 2004; 3: 17.
14. May MJ, D'Acquisto F, Madge LA, et al. Selective inhibition of NFkappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000; 289: 1550.
15. Tas SW, Vervoordeldonk MJ, Hajji N, et al. Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation. Arthritis Res Ther 2006; 8: R86.
16. Jimi E, Aoki K, Saito H, et al. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med 2004; 10: 617.
17. Shibata W, Maeda S, Hikiba Y, et al. Cutting edge: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J Immunol 2007; 179: 2681.
18. Okazaki M, Krupnick AS, Kornfeld CG, et al. A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant 2007; 7: 1672.
19. Krupnick AS, Lin X, Li W, et al. Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc 2009; 4: 86.
20. Fiser SM, Tribble CG, Long SM, et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg 2001; 121: 1069.
21. Zhao M, Fernandez LG, Doctor A, et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2006; 291: L1018.
22. Arkan MC, Hevener AL, Greten FR, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005; 11: 191.
23. Clausen BE, Burkhardt C, Reith W, et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8: 265.
24. Li ZW, Omori SA, Labuda T, et al. IKK beta is required for peripheral B cell survival and proliferation. J Immunol 2003; 170: 4630.
25. Yamane M, Liu M, Kaneda H, et al. Reperfusion-induced gene expression profiles in rat lung transplantation. Am J Transplant 2005; 5: 2160.
26. Zaph C, Troy AE, Taylor BC, et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 2007; 446: 552.
27. Chen LW, Egan L, et al. The two faces of IKK and NF-kappaB inhibition: Prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003; 9: 575.
28. Okazaki M, Gelman AE, Tietjens JR, et al. Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol 2007; 37: 625.
29. Van Antwerp DJ, Martin SJ, Kafri T, et al. Suppression of TNFalpha-induced apoptosis by NF-kappaB. Science 1996; 274: 787.
30. Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005; 11: 1173.
31. Broide DH, Lawrence T, Doherty T, et al. Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase betadependent genes in airway epithelium. Proc Natl Acad Sci USA 2005; 102: 17723.
32. Dai S, Hirayama T, Abbas S, et al. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 2004; 279: 37219.
33. Greten FR, Arkan MC, Bollrath J, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007; 130: 918.
34. Solt LA, Madge LA, Orange JS, et al. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta. J Biol Chem 2007; 282: 8724.
35. Fong CH, Bebien M, Didierlaurent A, et al. An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation. J Exp Med 2008; 205: 1269.
36. Kreisel D, Richardson SB, Li W, et al. Cutting edge: MHC class II expression by pulmonary nonhematopoietic cells plays a critical role in controlling local inflammatory responses. J Immunol 2010; 185: 3809.
37. Daley JM, Thomay AA, Connolly MD, et al. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 2008; 83: 64.